Exodus Point Capital Management, LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$144.95 - $152.29 $357,446 - $375,547	-2,466 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$83.14 - $145.99 $205,023 - $360,011	2,466 New	2,466 $359,000
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $348,962 - $557,131	-5,305 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $339,891 - $486,733	5,305 New	5,305 $363,000
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $1.99 Million - $3 Million	-30,564 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $1.8 Million - $2.38 Million	30,564 New	30,564 $1.99 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $818,397 - $1.08 Million	-21,894 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $871,162 - $1.47 Million	21,894 New	21,894 $959,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.